Skip to main content
Equibles

GABELLI FUNDS LLC

Position in LFCR — Lifecore Biomedical, Inc. De

CIK 1081407 Rye, NY
Back to LFCR Full portfolio

Position in LFCR

as of Jun 30, 2026 · filed Aug 12, 2026
Position Value
$70,875
+$20,655 QoQ
Shares Held
13,500
0.0% QoQ
Ownership
0.036%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#57
of 98 holders
Holding Since
Dec 2020
23 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in LFCR Over Time

Shares Held

Position Value (USD)

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

GABELLI FUNDS LLC holds $37,173,300 across 16 Drug Manufacturers - Specialty & Generic names. LFCR ranks #15 (0.2% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 TEVA
Teva Pharmaceutical Industries Ltd
 331,500 $11,231,220
2 PRGO
PERRIGO Co plc
 874,359 $9,084,590
3 ZTS
Zoetis Inc.
 69,200 $4,972,712
4 VTRS
Viatris Inc
 203,200 $3,226,816
5 ELAN
Elanco Animal Health Inc
 125,000 $3,076,250
6 LNTH
Lantheus Holdings, Inc.
 24,000 $2,662,560
7 SUPN
Supernus Pharmaceuticals, Inc.
 23,000 $1,069,730
8 INDV
Indivior Pharmaceuticals, Inc.
 13,860 $568,675

All Filings in LFCR

Export CSV
23 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $70,875 13,500
2026-03-31 $50,220 13,500
2025-12-31 $110,430 13,500
2025-09-30 $99,360 13,500
2025-06-30 $109,620 13,500
2025-03-31 $95,040 13,500
2024-12-31 $100,305 13,500
2024-09-30 $88,740 18,000
2024-06-30 $99,009 19,300
2024-03-31 $100,890 19,000
2023-12-31 $113,277 18,300
2023-09-30 $125,330 16,600
2023-06-30 $160,522 16,600
2023-03-31 $64,260 17,000
2022-12-31 $115,344 17,800
2022-09-30 $155,575 17,500
2022-06-30 $174,475 17,500
2022-03-31 $156,330 13,500
2021-12-31 $149,850 13,500
2021-09-30 $225,890 24,500
2021-06-30 $438,750 39,000
2021-03-31 $307,400 29,000
2020-12-31 $249,550 23,000